RicercaInizia una nuova ricerca
NOTA: è possibile cercare una corrispondenza esatta usando i doppi apici, ad es: "evoluzione della specie". Qualora si cerchi un identificativo, è consigliabile cercarlo in due modi differenti: tra apici con caratteri speciali es: "978-94-6366-274" oppure senza caratteri speciali solo come sequenza numerica: es 978946366274.
arallel comparison of 68Ga-Prostate Specific Membrane Antigen PET-CT and PRIMUS in primary prostate cancer diagnosis
2019-01-01 Lopci, E; Lughezzani, G; Castello, A; Saita, A; Colombo, P; Buffi, Nm; Lo Iacono, N; Hurle, R; Marzo, K; Leonardi, L; Peschechera, R; Benetti, A; Zandegiacomo, S; Pasini, L; Casale, P; Diana, P; Bevilacqua, G; Mazziotti, E; Balzarini, L; Chiti, A; Guazzoni, G; Lazzeri, M
ASSESSING THE DIAGNOSTIC ACCURACY OF MICRO-ULTRASOUND FOR THE DETECTION OF CLINICALLY SIGNIFICANT PROSTATE CANCER: RESULTS FROM A SINGLE-INSTITUTIONAL PRELIMINARY EXPERIENCE
2018-01-01 Lughezzani, G; Maffei, D; Lazzeri, M; Cardone, P; Lista, G; Colombo, P; Casale, P; Saita, A; Buffi, N; Hurle, R; Guazzoni, G
ASSESSMENT OF MORTALITY FOR NON CANCER-RELATED MORTALITY IN PATIENTS WITH HISTOLOGICALLY PROVEN SMALL RENAL MASSES MANAGED NON-SURGICALLY
2010-01-01 Jeldres, C; Lughezzani, G; Budaus, L; Liberman, D; Sun, M; Shariat, Sf; Perrotte, P; Graefen, M; Montorsi, F; Karakiewicz, Pi
ASSESSMENT OF MORTALITY FOR NON CANCER-RELATED MORTALITY IN PATIENTS WITH HISTOLOGICALLY PROVEN SMALL RENAL MASSES MANAGED NON-SURGICALLY
2010-01-01 Jeldres, C; Lughezzani, G; Sun, M; Budaus, L; Thuret, R; Liberman, D; Kassouf, W; Shariat, Sf; Widmer, H; Arjane, P; Perrotte, P; Huland, H; Graefen, M; Montorsi, F; Karakiewicz, Pi
CLINICAL PERFORMANCE OF SERUM ISOFORM [-2]PROPSA (P2PSA) AND ITS DERIVATIVES, NAMELY %P2PSA AND PHI (PROSTATE HEALTH INDEX) IN MEN WITH FAMILY HISTORY OF PROSTATE CANCER. RESULTS FROM A MULTICENTRIC EUROPEAN STUDY (PROMETHEUS PROJECT)
2013-01-01 Lazzeri, M; Haese, A; de la Taille, A; Mcnicholas, T; Palou, J; Abrate, A; Lughezzani, G; Larcher, A; Lista, G; Cestari, A; Maga, T; Renter, A; Bosset, Po; Le Corvoisier, P; Fowler, L; Roux, Jwt; Breda, A; de la Torre, P; Bini, V; Guazzoni, G
COMPARISON BETWEEN COMPLICATION RATES, LENGTH OF STAY AND COSTS OF MINIMAL INVASIVE VS. OPEN RADICAL PROSTATECTOMY
2010-01-01 Budaus, L; Lughezzani, G; Sun, M; Liberman, D; Shariat, Sf; Jeldres, C; Steuber, T; Isbarn, H; Haese, A; Salomon, G; Heinzer, H; Huland, H; Graefen, M; Karakiewicz, Pi
COMPARISON OF MICRO-ULTRASOUND AND MULTIPARAMETRIC MRI IMAGING FOR PROSTATE CANCER: AN INTERNATIONAL META-ANALYSIS
2019-01-01 Lughezzani, G; Astobieta, A; Staerman, F; Klein, Ea; Abouassaly, R; El-Shefai, A; Gregg, E
Correlation of chronic histologic prostatic inflammation (CHPI) in biopsy specimens with serum isoform [-2]proPSA (p2PSA), %p2PSA and PHI (prostate health index) in men undergoing prostate biopsy for suspected PCa
2012-01-01 Gadda, G; Lazzeri, M; Freschi, M; Sangalli, M; Larcher, A; Scattoni, V; Lughezzani, G; Nava, L; Buffi, N; Rigatti, P; Guazzoni, G
DECREASED SURVIVAL OF BLACK AMERICANS WITH TESTICULAR CANCER: A CONTEMPORARY POPULATION-BASED ANALYSIS
2010-01-01 Liberman, D; Badaus, L; Lughezzani, G; Sun, M; Thuret, R; Kassouf, W; Arjane, P; Widmer, H; Montorsi, F; Shariat, Sf; Perrotte, P; Karakiewicz, Pi
Definition of the Limit of Detection (LoD) for serum isoform [−2]proPSA in patients with recurrent prostate cancer after radical prostatectomy: An analytic study
2013-01-01 Ceriotti F., Pontillo M; Fasoli L., Lazzeri M; Lughezzani, G; Lista, G; Larcher, A; Cestari, A; Buffi, N; Fuzzi, G; Guazzoni, G
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| arallel comparison of 68Ga-Prostate Specific Membrane Antigen PET-CT and PRIMUS in primary prostate cancer diagnosis | 1-gen-2019 | Lopci, E; Lughezzani, G; Castello, A; Saita, A; Colombo, P; Buffi, Nm; Lo Iacono, N; Hurle, R; Marzo, K; Leonardi, L; Peschechera, R; Benetti, A; Zandegiacomo, S; Pasini, L; Casale, P; Diana, P; Bevilacqua, G; Mazziotti, E; Balzarini, L; Chiti, A; Guazzoni, G; Lazzeri, M | |
| ASSESSING THE DIAGNOSTIC ACCURACY OF MICRO-ULTRASOUND FOR THE DETECTION OF CLINICALLY SIGNIFICANT PROSTATE CANCER: RESULTS FROM A SINGLE-INSTITUTIONAL PRELIMINARY EXPERIENCE | 1-gen-2018 | Lughezzani, G; Maffei, D; Lazzeri, M; Cardone, P; Lista, G; Colombo, P; Casale, P; Saita, A; Buffi, N; Hurle, R; Guazzoni, G | |
| ASSESSMENT OF MORTALITY FOR NON CANCER-RELATED MORTALITY IN PATIENTS WITH HISTOLOGICALLY PROVEN SMALL RENAL MASSES MANAGED NON-SURGICALLY | 1-gen-2010 | Jeldres, C; Lughezzani, G; Budaus, L; Liberman, D; Sun, M; Shariat, Sf; Perrotte, P; Graefen, M; Montorsi, F; Karakiewicz, Pi | |
| ASSESSMENT OF MORTALITY FOR NON CANCER-RELATED MORTALITY IN PATIENTS WITH HISTOLOGICALLY PROVEN SMALL RENAL MASSES MANAGED NON-SURGICALLY | 1-gen-2010 | Jeldres, C; Lughezzani, G; Sun, M; Budaus, L; Thuret, R; Liberman, D; Kassouf, W; Shariat, Sf; Widmer, H; Arjane, P; Perrotte, P; Huland, H; Graefen, M; Montorsi, F; Karakiewicz, Pi | |
| CLINICAL PERFORMANCE OF SERUM ISOFORM [-2]PROPSA (P2PSA) AND ITS DERIVATIVES, NAMELY %P2PSA AND PHI (PROSTATE HEALTH INDEX) IN MEN WITH FAMILY HISTORY OF PROSTATE CANCER. RESULTS FROM A MULTICENTRIC EUROPEAN STUDY (PROMETHEUS PROJECT) | 1-gen-2013 | Lazzeri, M; Haese, A; de la Taille, A; Mcnicholas, T; Palou, J; Abrate, A; Lughezzani, G; Larcher, A; Lista, G; Cestari, A; Maga, T; Renter, A; Bosset, Po; Le Corvoisier, P; Fowler, L; Roux, Jwt; Breda, A; de la Torre, P; Bini, V; Guazzoni, G | |
| COMPARISON BETWEEN COMPLICATION RATES, LENGTH OF STAY AND COSTS OF MINIMAL INVASIVE VS. OPEN RADICAL PROSTATECTOMY | 1-gen-2010 | Budaus, L; Lughezzani, G; Sun, M; Liberman, D; Shariat, Sf; Jeldres, C; Steuber, T; Isbarn, H; Haese, A; Salomon, G; Heinzer, H; Huland, H; Graefen, M; Karakiewicz, Pi | |
| COMPARISON OF MICRO-ULTRASOUND AND MULTIPARAMETRIC MRI IMAGING FOR PROSTATE CANCER: AN INTERNATIONAL META-ANALYSIS | 1-gen-2019 | Lughezzani, G; Astobieta, A; Staerman, F; Klein, Ea; Abouassaly, R; El-Shefai, A; Gregg, E | |
| Correlation of chronic histologic prostatic inflammation (CHPI) in biopsy specimens with serum isoform [-2]proPSA (p2PSA), %p2PSA and PHI (prostate health index) in men undergoing prostate biopsy for suspected PCa | 1-gen-2012 | Gadda, G; Lazzeri, M; Freschi, M; Sangalli, M; Larcher, A; Scattoni, V; Lughezzani, G; Nava, L; Buffi, N; Rigatti, P; Guazzoni, G | |
| DECREASED SURVIVAL OF BLACK AMERICANS WITH TESTICULAR CANCER: A CONTEMPORARY POPULATION-BASED ANALYSIS | 1-gen-2010 | Liberman, D; Badaus, L; Lughezzani, G; Sun, M; Thuret, R; Kassouf, W; Arjane, P; Widmer, H; Montorsi, F; Shariat, Sf; Perrotte, P; Karakiewicz, Pi | |
| Definition of the Limit of Detection (LoD) for serum isoform [−2]proPSA in patients with recurrent prostate cancer after radical prostatectomy: An analytic study | 1-gen-2013 | Ceriotti F., Pontillo M; Fasoli L., Lazzeri M; Lughezzani, G; Lista, G; Larcher, A; Cestari, A; Buffi, N; Fuzzi, G; Guazzoni, G |
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile
Opzioni
Scopri
Tipologia
- 1 Contributo su Rivista 104
- 1 Contributo su Rivista::1.5 Abst... 104
Data di pubblicazione
- 2020 - 2021 1
- 2010 - 2019 100
- 2008 - 2009 3
Rivista
- THE JOURNAL OF UROLOGY 48
- EUROPEAN UROLOGY. SUPPLEMENTS 41
- ANTICANCER RESEARCH 7
- EUROPEAN JOURNAL OF NUCLEAR MEDIC... 3
- INTERNATIONAL UROGYNECOLOGY JOURNAL 1
- JOURNAL OF CLINICAL ONCOLOGY 1
- NEUROUROLOGY AND URODYNAMICS 1
- THE JOURNAL OF NUCLEAR MEDICINE 1
- VIRCHOWS ARCHIV 1
Lingua
- eng 60
Accesso al fulltext
- no fulltext 89
- reserved 15